Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

A Burning FDA Hiring Freeze Question: What About User Fee-Supported Staff?

Executive Summary

Industry worries about user fee programs as US FDA could wait weeks before finding out how President Trump's hiring freeze affects it.

You may also be interested in...



Ostroff: Administration Coming Up To Speed On Planned FDA Guidances

There’s been a dearth of guidances from US FDA since Donald Trump's inauguration, but the acting FDA commissioner says that simply reflects the new administration catching up on what's in the pipeline. In a speech at FDLI's annual meeting, Stephen Ostroff struck a positive tone.

The Freeze Thaws: US FDA Allowed To Hire Staff For Cures, User Fee Activity

White House allowed agency to hire some new employees, but lawmakers remain concerned about federal hiring freeze's effect on FDA.

CDER’s 50 Open Leadership Posts Could Be Bigger Hiring Challenges After Trump Freeze

President Trump’s hiring freeze on civilian employees will exacerbate the Center for Drugs Evaluation & Research’s existing difficulties in recruiting and retaining qualified individuals. CDER is currently 591 positions under the hiring ceiling, include 50 open positions within CDER management.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS119899

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel